ArticleCell genomics2025
Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality.
Chelsea E Cunningham et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it